µå·¯±×ÀÎÆ÷¸ÞÀÎ
µå·¯±×ÀÎÆ÷¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù.
left1
  ÀǾàÇ°   Á¦Ç°½Äº°   º¹¾àÁöµµ   »óÈ£ÀÛ¿ë   ½ÅÀå¾Ö¾à¿ë·®   º¸Çè½É»ç±âÁØ  
right1
left2
ÀǾàÇ°°Ë»ö line ¾àÈ¿ºÐ·ù line ÀûÀÀÁõ line Á¦Á¶,ÆǸŻç line ¼öÀÔÀǾàÇ° line Èñ±ÍÀǾàÇ° line Ç×Á¤ÀǾàÇ° line ÇÑ¿Ü,¸¶¾à line ¿À³²¿ë¿ì·Á  
right2
ºÐ·ù¾øÀ½
 
´Ü¹éÁú ÀλêÈ­È¿¼Ò ¾ïÁ¦Á¦(Protein kinase inhibitors)

´ÜÀÏÁ¦ ÃÑ 108°³
¼ººÐ¸í Á¦Çü ÇØ´çÁ¦Ç°¸®½ºÆ®
selpercatinib 40mgĸ½¶ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
selpercatinib 80mgĸ½¶ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
asciminib hydrochloride 21.62mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
asciminib hydrochloride 43.24mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
mobocertinib succinate 48.06mgĸ½¶ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
pemigatinib 13.5mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
pemigatinib 9mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
pemigatinib 4.5mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
[6]
º¹ÇÕÁ¦ ÃÑ0°³
¼ººÐ¸í Á¦Çü ÇØ´çÁ¦Ç°¸®½ºÆ®
°Ë»ö°á°ú°¡ ¾ø½À´Ï´Ù.
 
ºñÆ®µå·¯±×ÀÎÆ÷